van der Reis MI - Search Results

1

A new epidemiological aid in deciding whether to continue or stop a treatment.

Elshout M, van der Reis MI, Webers CA, La Heij EC, Hendrikse F, Schouten JS. Elshout M, et al. Among authors: van der reis mi. Invest Ophthalmol Vis Sci. 2012 Jul 1;53(8):4331-6. doi: 10.1167/iovs.11-9242. Invest Ophthalmol Vis Sci. 2012. PMID: 22661474

2

A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections.

van der Reis MI, La Heij EC, De Jong-Hesse Y, Ringens PJ, Hendrikse F, Schouten JS. van der Reis MI, et al. Retina. 2011 Sep;31(8):1449-69. doi: 10.1097/IAE.0b013e3182278ab4. Retina. 2011. PMID: 21817960 Review.

3

The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters.

Elshout M, van der Reis MI, Webers CA, Schouten JS. Elshout M, et al. Among authors: van der reis mi. Graefes Arch Clin Exp Ophthalmol. 2014 Dec;252(12):1911-20. doi: 10.1007/s00417-014-2641-3. Epub 2014 Apr 29. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 24777708

4

Distinguishing between Better and Worse Visual Acuity by Studying the Correlation with Quality of Life in Neovascular Age-Related Macular Degeneration.

Elshout M, van der Reis MI, de Jong-Hesse Y, Webers CA, Schouten JS. Elshout M, et al. Among authors: van der reis mi. Ophthalmology. 2016 Nov;123(11):2408-2412. doi: 10.1016/j.ophtha.2016.07.015. Epub 2016 Aug 25. Ophthalmology. 2016. PMID: 27568997

5

Tracing the natural course of visual acuity and quality of life in neovascular age-related macular degeneration: a systematic review and quality of life study.

Elshout M, Webers CA, van der Reis MI, de Jong-Hesse Y, Schouten JS. Elshout M, et al. Among authors: van der reis mi. BMC Ophthalmol. 2017 Jul 11;17(1):120. doi: 10.1186/s12886-017-0514-3. BMC Ophthalmol. 2017. PMID: 28693519 Free PMC article. Review.

6

A systematic review on the quality, validity and usefulness of current cost-effectiveness studies for treatments of neovascular age-related macular degeneration.

Elshout M, Webers CAB, van der Reis MI, Schouten JSAG. Elshout M, et al. Among authors: van der reis mi. Acta Ophthalmol. 2018 Dec;96(8):770-778. doi: 10.1111/aos.13824. Epub 2018 Jun 4. Acta Ophthalmol. 2018. PMID: 29862641 Free article.

7

A systematic approach to evaluate practice-based process- and outcome data applied to the treatment of neovascular age-related macular degeneration.

van der Reis MI, Elshout M, Berendschot TTJM, de Jong-Hesse Y, Webers CAB, Schouten JSAG. van der Reis MI, et al. BMC Ophthalmol. 2020 Jan 9;20(1):21. doi: 10.1186/s12886-020-1303-y. BMC Ophthalmol. 2020. PMID: 31918701 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters